Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Colorectal Neoplasms and meta-analysis and BRAF[original query] |
|---|
| The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta-analysis. PloS one 2013 8 (6): e65995. Yuan Zi-Xu, Wang Xiao-Yan, Qin Qi-Yuan, Chen De-Feng, Zhong Qing-Hua, Wang Lei, Wang Jian-Pi |
| Predictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a meta-analysis. Journal of digestive diseases 2013 Aug 14 (8): 409-16. Xu Qi, Xu An Tao, Zhu Ming Ming, Tong Jin Lu, Xu Xi Tao, Ran Zhi H |
| BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2013 Dec 15 (12): e711-8. Clancy C, Burke J P, Kalady M F, Coffey J |
| BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis. PloS one 2014 9 (3): e90607. Chen Dong, Huang Jun-Fu, Liu Kai, Zhang Li-Qun, Yang Zhao, Chuai Zheng-Ran, Wang Yun-Xia, Shi Da-Chuan, Huang Qing, Fu Wei-Li |
| The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64. Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M |
| BRAF V600E mutation as a predictive factor of anti-EGFR monoclonal antibodies therapeutic effects in metastatic colorectal cancer: a meta-analysis. Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 2014 Dec 29 (4): 197-203. Wang Qi, Hu Wei-guo, Song Qi-bin, Wei J |
| Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies. Molecular biology reports 2014 Mar 41 (3): 1291-8. Cui Dandan, Cao Dan, Yang Yu, Qiu Meng, Huang Ying, Yi Che |
| Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer. British journal of cancer 2015 Jun 112 (12): 1888-94. Rowland A, Dias M M, Wiese M D, Kichenadasse G, McKinnon R A, Karapetis C S, Sorich M |
| Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. European journal of cancer (Oxford, England : 1990) 2015 Mar 51 (5): 587-94. Pietrantonio Filippo, Petrelli Fausto, Coinu Andrea, Di Bartolomeo Maria, Borgonovo Karen, Maggi Claudia, Cabiddu Mary, Iacovelli Roberto, Bossi Ilaria, Lonati Veronica, Ghilardi Mara, de Braud Filippo, Barni Sand |
| Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy. World journal of gastroenterology 2016 Aug 22 (30): 6944-54. Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco |
| Efficacy of cetuximab-based chemotherapy in metastatic colorectal cancer according to RAS and BRAF mutation subgroups: A meta-analysis. Molecular and clinical oncology 2016 Jun 4 (6): 1017-1024. Lin L I, Chen Lu-Lu, Wang You, Meng Xiang-Yu, Liang Chen, Zhou Fu-Xia |
| Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials. PloS one 2016 11 (5): e0154795. Zhu Lizhen, Dong Caixia, Cao Ying, Fang Xuefeng, Zhong Chenhan, Li Dan, Yuan Yi |
| Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Critical reviews in oncology/hematology 2016 Jan . Passiglia Francesco, Bronte Giuseppe, Bazan Viviana, Galvano Antonio, Vincenzi Bruno, Russo Anton |
| BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 0 23 (3): 144-149. Li Yujie, Li Wei |
| Retraction: Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta analysis. Journal of cancer research and therapeutics 0 13 (1): 156. Authors are not available |
| Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta-analysis. Journal of cancer research and therapeutics 2016 Dec 12 (Supplement): C191-C198. Lin Li, Chen Guang-Yong, Xu Chun-Wei, Wang Hai-Yan, Wu Yong-Fang, Fang Mei- |
| Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials. British journal of cancer 2017 Dec 117 (12): 1768-1776. Goey Kaitlyn K H, Elias Sjoerd G, Hinke Axel, van Oijen Martijn G H, Punt Cornelis J A, Hegewisch-Becker Susanna, Arnold Dirk, Koopman Miri |
| Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer. Clinical and translational gastroenterology 2017 Oct 8 (10): e124. Staudacher Jonas J, Yazici Cemal, Bul Vadim, Zeidan Joseph, Khalid Ahmer, Xia Yinglin, Krett Nancy, Jung Barba |
| Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Translational oncology 2018 8 11 (5): 1188-1201. Advani Shailesh M, Advani Pragati, DeSantis Stacia M, Brown Derek, VonVille Helena M, Lam Michael, Loree Jonathan M, Mehrvarz Sarshekeh Amir, Bressler Jan, Lopez David S, Daniel Carrie R, Swartz Michael D, Kopetz Sco |
| Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer metastasis reviews 2018 Jan . Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong |
| PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis. Acta oncologica (Stockholm, Sweden) 2019 9 59 (1): 66-74. Jin Juan, Shi Yaqin, Zhang Shu, Yang Shuof |
| The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression. Scientific reports 2019 9 9 (1): 13463. Thomas Rachael, Trapani Davide, Goodyer-Sait Lily, Tomkova Marketa, Fernandez-Rozadilla Ceres, Sahnane Nora, Woolley Connor, Davis Hayley, Chegwidden Laura, Kriaucionis Skirmantas, Maughan Timothy, Leedham Simon, Palles Claire, Furlan Daniela, Tomlinson Ian, Lewis Annabel |
| Clinicopathological Significance of BRAF Mutation in Colorectal Cancer: An Updated Meta-Analysis. Journal of Cancer 2019 7 10 (10): 2332-2341. Wang Jianhua, Shen Jiajia, Huang Chi, Cao Meng, Shen Lizo |
| MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis. Pathology, research and practice 2019 Dec 152791. Wu Moxin, Kim Yong Sung, Ryu Han-Seung, Choi Suck Chei, Kim Keun Young, Park Won Cheol, Kim Min Seob, Myung Ji Yeon, Choi Hyun Seok, Kim Eui Joong, Lee Moon You |
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
| A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer. Gastroenterology research 2020 11 13 (5): 184-198. Levin-Sparenberg Elizabeth, Bylsma Lauren C, Lowe Kimberly, Sangare Laura, Fryzek Jon P, Alexander Dominik |
| Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases. American journal of surgery 2021 Sep . Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni |
| The prognostic and predictive impact of BRAF mutations in deficient mismatch repair/microsatellite instability-high colorectal cancer: systematic review/meta-analysis. Future oncology (London, England) 2021 7 17 (31): 4221-4231. Park Robin, Lopes Laercio, Lee Sunggon, Riano Ivy, Saeed Anwa |
| KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis. Caspian journal of internal medicine 2020 11 (4): 355-369. Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav |
| The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review. Medicina (Kaunas, Lithuania) 2022 7 58 (7): . Liu Xueting, Huang Litao, Liu Menghan, Wang Z |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: